Compounded with
Semaglutide
Not verified in the bound record.
Tirzepatide
Not verified in the bound record.
Product evidence does not establish current availability.
Pharmacy evidence record · researched 2026-08-20
AnazaoHealth
AnazaoHealth Corporation
6 citations5 action records4 explicit unknowns
Locations in the source record
- 5401 Hangar Ct, Tampa, FL 33634
- 7465 W Sunset Rd #1200, Las Vegas, NV 89113
Services named by sources
- 503A patient-specific compounding
- 503B outsourcing-facility services
- Weight management
- Age management
- Pain management
- IV and injection therapy
Regulatory compliance
503 pathway evidence
A pathway label describes which federal rules apply — it is not a quality claim.
Section 503A
Source-backed pathway evidence
Anazao describes this as a traditional patient-specific 503A pharmacy.
Section 503B
Source-backed pathway evidence
verified current fda registry
Telehealth providers
No provider relationship is verified in the bound sources.
Clinic Scout links a provider only when an explicit source names the relationship.
Regulatory history
Actions stay dated and bounded.
FDA current 503B registry, warning-letter, Form 483 and compounding-action sources were checked. Nevada and Florida state-board action searches were bounded; no state action was verified.
U.S. Food and Drug Administration · 2021-08-18
Warning Letter
FDA's letter followed a September 2019 inspection and described violations including inadequate production and process-control procedures.
Status not statedU.S. Food and Drug Administration · 2019-09-19
Form FDA 483
issuedU.S. Food and Drug Administration · 2022-07-29
Form FDA 483
issuedU.S. Food and Drug Administration · 2024-09-23
Form FDA 483
issuedU.S. Food and Drug Administration · 2025-08-08
Form FDA 483
FDA observed inadequate written production/process-control procedures, including pellet content-uniformity validation.
open_on_current_registryWhat remains unverified
- Comprehensive state-license footprint
- Explicit semaglutide relevance
- Explicit tirzepatide relevance
- State-board actions
Patient reviews
Share your experience for moderationNo Clinic Scout patient reviews are published for this pharmacy. Submissions go through manual moderation before anything appears here.
What this record verifies for you
6 evidence dimensions carry dated, source-backed verification.
Each line traces to a citation in the source list below — read the exact captured wording before relying on it.
- dated source ledger: 6 first-party/regulator citations with URL, accessed date, and exact supporting quote.
- legal entity provenance: Legal entity recorded as AnazaoHealth Corporation with status verified_fda.
- regulator verified state evidence: 1 regulator-verified state record(s) preserved with field-level provenance.
- regulatory action timeline: 5 dated regulatory/action record(s) with bounded summaries and regulator citations.
- 503 status provenance: 503A/503B fields preserve pathway, source status, and current-versus-historical limits from the bound research.
- transparent unknowns: 4 unresolved field(s) are explicitly named and prevented from rendering as facts.
No superiority claim is made for review volume, ratings, or patient sentiment.
Sources and exact captured wording
- first_party · accessed 2026-08-20
Founded in 1997 ... We have a 30,000-square-foot 503B FDA-Registered Outsourcing Facility in Las Vegas and a 54,000-square-foot traditional 503A compounding pharmacy in Tampa.
- first_party · accessed 2026-08-20
Regulated and inspected by State Boards of Pharmacy, our traditional compounding pharmacy focuses on compounding patient-specific preparations pursuant to a prescription for individual patient use.
- first_party · accessed 2026-08-20
AnazaoHealth provides preparations from our 503B FDA-registered outsourcing facility and 503A patient-specific pharmacy focused on weight management.
- fda · accessed 2026-08-20
AnazaoHealth Corporation, Las Vegas, NV | Vic Williams 800-995-4363 | 9/23/2014 | 12/30/2025 | 8/8/2025 | Yes | No | Open7 | Yes
- fda · accessed 2026-08-20
You registered your facility with the U.S. Food and Drug Administration (FDA) as an outsourcing facility under section 503B ... on September 23, 2014. From September 9, 2019, to September 19, 2019, an FDA investigator inspected your facility.
- fda · accessed 2026-08-20
OBSERVATION 1: Your firm failed to establish adequate written procedures for production and process controls designed to assure that the drug products have the identity, strength, purity, and quality that they are purported or represented to possess.
Questions readers ask
Is AnazaoHealth legit?
GLP Clinic Scout does not issue a blanket legitimacy verdict. This research record preserves 6 dated first-party or regulator citation(s), 5 regulatory/action record(s), and 4 explicitly unresolved field(s). Review the cited evidence and current license status before making a decision.